Abstract
The purpose of this study is to find out whether there are broad cross-reactivity between antibacterial and non-antibacterial sulfonamide agents, the method of the study contained two parts, one is literature research mainly from PubMed database by using the MeSH terms (“Drug name” + allergy); (“Drug name” + hypersensitivity); (“Drug name” + cross-allergenicity) and (“Drug name + cross-reactivity), the search drugs included some commonly seen medication such as carbonic anhydrase inhibitor, COX-2 inhibitor, loop diuretic, sulfonylurea, thiazide and certain antiviral drugs; the other parts of this thesis is to conduct a statistical review, we screen out patients who have a previous allergic history of antimicrobial sulfonamides from hospital medical record system during Jan 1st, 2015 to Dec 31th, 2016, we did a descriptive statistics of general patients medical information, analyze the suspect cases which patients present potential allergic reaction after using non-antimicrobial sulfonamides agents. Result of literature research reveal there are no convincing evidences and research to confirm there are bored allergenicity between non-antimicrobial sulfonamides and antimicrobial sulfonamide in the aspects of chemical structure, immunological study, and large scale population study as well; Result of hospital patient’s statistics found out there are only 3 suspected cases that the patients were having adverse effect during their pharmacotherapy from 506 cases. However, we did not found any strong correlation of broad allergenicity between non-antimicrobial sulfonamides and antimicrobial sulfonamides from these suspected cases. Conclusion: There is minimal evidence of cross-reactivity between the antimicrobial sulfonamides and the non-antimicrobial sulfonamides. However, the non-antimicrobial sulfonamides are rarely implicated in hypersensitivity reactions as well, so it is impossible to say with certainty that cross-reactivity does not occur.
Keywords
References
Bigby M, Jick S, Jick H, et al. Drug-Induced Cutaneous Reactions. A report from the Boston Collaborative Drug Surveillance Program on 15,438 consecutive inpatients, 1975 to 1982. JAMA.1986; 256(24): 3358.
Knowles S, Shapiro L, Shear NH. Should Celecoxib Be Contraindicated in Patients Who Are Allergic to Sulfonamides? Revisiting the meaning of 'sulfa' allergy. Drug Saf. 2001; 24(4): 239-247.
Hemstreet BA, Page RL. Sulfonamide Allergies and Outcomes Related to Use of Potentially Cross-Reactive Drugs in Hospitalized Patients. Pharmacotherapy. 2006; 26(4): 551-557.
Jick H. Adverse Reactions to Trimethoprim-Sulfamethoxazole in Hospitalized Patients. Rev Infect Dis. 1982; 2(2): 426-428.
Dibbern DA, Montanaro A. Allergies to sulfonamide antibiotics and sulfur-containing drugs. Ann Allergy Asthma Immunol. 2008; 100(2): 91-101.
Gruchalla RS, Sullivan TJ. Detection of human IgE to sulfamethoxazole by skin testing with sulfamethoxazoyl-poly-L-tyrosine. J Allergy Clin Immunol, 1991; 88(5): 784-792.
Carr A, Penny R, Cooper DA. Efficacy and safety of rechallenge with low-dose trimethoprim-sulphamethoxazole in previously hypersensitive HIV-infected patients. AIDS. 1993; 7(1): 65-72.
Gruchalla RS. Diagnosis of allergic reactions to sulfonamides. Allergy. 1999; 54: 28-32.
Asero R. Detection of Patients with Multiple Drug Allergy Syndrome by Elective Tolerance Tests. Ann Allergy Asthma Immunol.1998; 80(2): 185-188.
Strom BL, Schinnar R, Apter AJ, et al. Absence of cross-reactivity between sulfonamide antibiotics and sulfonamide nonantibiotics. N Engl J Med. 2003; 138(1):178-178.
Wulf NR, Matuszewski KA. Sulfonamide cross-reactivity: is there evidence to support broad cross-allergenicity?. Am J Health Syst Pharm. 2013; 70(17): 1483-1494.
Hemstreet BA, Page RL. Sulfonamide Allergies and Outcomes Related to Use of Potentially Cross?Reactive Drugs in Hospitalized Patients. Pharmacotherapy. 2006; 26(4): 551-557.
Lee AG, Anderson R, Kardon RH, et al. Presumed “Sulfa allergy” in patients with intracranial hypertention treated with acetazolmide or furosemide: cross reactivity, myth, or reality? Am J Ophthalmol. 2004; 138(1):114-118.
Johnson KK, Green DL, Rife JP, et al. Sulfonamide cross-reactivity: fact or fiction. Ann Pharmacother. 2005; 39(2): 290-301.
Zawodniak A, Lochmatter P, Beeler A, et al. Cross-reactivity in drug hypersensitivity reactions to sulfasalazine and sulfamethoxazole. Int Arch Allergy Immunol. 2010; 153(2):152-156.
Lori, E, Shapiro, et al. Safety of celecoxib in individuals allergic to sulfonamide: a pilot study. Drug Saf. 2018, 26:187-195.
Patterson R, Bello A-E, Lefkowith J. Immunologic tolerability profile of celecoxib. Clin Ther. 2000; 21(12): 2065-2079.
Agrawal S, Agarwalla A. Dapsone Hypersensitivity Syndrome: A clinico-epidemiological review. J Dermatol. 2005; 32(11):883-889.
Chichmanian RM, Papasseudi G, Hieronimus S, et al. Hypersensitivity to hypoglycemic sulfonylurea compounds. Are there cross-reactions?. Thérapie. 1991; 46(2): 163-167.
Refbacks
- There are currently no refbacks.
Copyright (c) 2020 Journal of Pharmaceutical and Biomedical Sciences
![Creative Commons License](http://i.creativecommons.org/l/by-nc-nd/4.0/88x31.png)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.